Comera Life Sciences Stock Fundamentals
| CMRAWDelisted Stock | USD 0.04 0 5.07% |
Comera Life Sciences fundamentals help investors to digest information that contributes to Comera Life's financial success or failures. It also enables traders to predict the movement of Comera Stock. The fundamental analysis module provides a way to measure Comera Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Comera Life stock.
Comera |
Comera Life Sciences Company Number Of Shares Shorted Analysis
Comera Life's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Comera Life Number Of Shares Shorted | 300 |
Most of Comera Life's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Comera Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Comera Life Sciences has 300 of outstending shares currently sold short by investors. This is 99.99% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.99% higher than that of the company.
Comera Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Comera Life's current stock value. Our valuation model uses many indicators to compare Comera Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Comera Life competition to find correlations between indicators driving Comera Life's intrinsic value. More Info.Comera Life Sciences is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Comera Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Comera Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Comera Life's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Comera Life could also be used in its relative valuation, which is a method of valuing Comera Life by comparing valuation metrics of similar companies.Comera Life is currently under evaluation in number of shares shorted category among its peers.
Comera Fundamentals
| Return On Equity | -16.29 | |||
| Return On Asset | -1.19 | |||
| Operating Margin | (15.82) % | |||
| Number Of Shares Shorted | 300 | |||
| Revenue | 1 M | |||
| EBITDA | (7.55 M) | |||
| Net Income | (9.01 M) | |||
| Cash And Equivalents | 3.86 M | |||
| Cash Per Share | 2.85 X | |||
| Total Debt | 775.05 K | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 4.26 X | |||
| Book Value Per Share | (12.62) X | |||
| Cash Flow From Operations | (6.66 M) | |||
| Earnings Per Share | (6.08) X | |||
| Number Of Employees | 12 | |||
| Beta | 0.41 | |||
| Total Asset | 3.73 M | |||
| Retained Earnings | (34.9 M) | |||
| Working Capital | (2 M) | |||
| Z Score | -20.17 | |||
| Net Asset | 3.73 M |
About Comera Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Comera Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Comera Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Comera Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts. Comera Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Comera Stock
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |